New drug combo targets Hard-to-Treat GI cancers
NCT ID NCT07280377
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This study is for people with advanced or metastatic gastrointestinal cancers, including anal and pancreatic cancers. Researchers are testing a combination of two drugs, pelareorep and atezolizumab, to see if they are safe and can shrink tumors or slow disease growth. About 122 participants will join this early-phase trial to help find better treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asklepios Kliniken Hamburg GmbH
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 22763, Germany
-
Caritasklinikum Saarbrücken St. Theresia
RECRUITINGSaarbrücken, Saarland, 66113, Germany
-
Charité Universitätsklinikum Berlin
RECRUITINGBerlin, State of Berlin, 13353, Germany
-
Gemeinschaftspraxis Dr. Med Bernhard Heinreich
RECRUITINGAugsburg, Bavaria, 86150, Germany
-
Hämatologisch-Onkologische Praxis Eppendorf
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 20249, Germany
-
Klinikum Chemnitz gGmbH
RECRUITINGChemnitz, Saxony, 09116, Germany
-
Klinikum der Universität München
RECRUITINGMünchen, Bavaria, 81377, Germany
-
Krankenhaus Nordwest
RECRUITINGFrankfurt am Main, Hesse, 60488, Germany
-
Nationales Centrum für Tumorerkrankungen Heidelberg
RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
-
SLK-Kliniken Heilbronn GmbH
RECRUITINGHeilbronn, Baden-Wurttemberg, 74078, Germany
-
St. Josef-Hospìtal, Bochum
RECRUITINGBochum, North Rhine-Westphalia, 44791, Germany
-
Universität Leipzig
RECRUITINGLeipzig, Saxony, 04103, Germany
-
Universitätsklinikum Tübingen
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
Universitätsklinikum Ulm
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
-
Universitätsmedizin Mainz
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
Conditions
Explore the condition pages connected to this study.